[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO157368B - Fremgangsmaate til fremstilling av faste legemiddeltilberedninger inneholdende nifedipin. - Google Patents

Fremgangsmaate til fremstilling av faste legemiddeltilberedninger inneholdende nifedipin. Download PDF

Info

Publication number
NO157368B
NO157368B NO812879A NO812879A NO157368B NO 157368 B NO157368 B NO 157368B NO 812879 A NO812879 A NO 812879A NO 812879 A NO812879 A NO 812879A NO 157368 B NO157368 B NO 157368B
Authority
NO
Norway
Prior art keywords
nifedipine
preparation
specific surface
crystals
preparations containing
Prior art date
Application number
NO812879A
Other languages
English (en)
Norwegian (no)
Other versions
NO812879L (no
Inventor
Ahmed Hegasy
Klaus-Dieter Ramsch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6111496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO157368(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO812879L publication Critical patent/NO812879L/no
Publication of NO157368B publication Critical patent/NO157368B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NO812879A 1980-09-09 1981-08-25 Fremgangsmaate til fremstilling av faste legemiddeltilberedninger inneholdende nifedipin. NO157368B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803033919 DE3033919A1 (de) 1980-09-09 1980-09-09 Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO812879L NO812879L (no) 1982-03-10
NO157368B true NO157368B (no) 1987-11-30

Family

ID=6111496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812879A NO157368B (no) 1980-09-09 1981-08-25 Fremgangsmaate til fremstilling av faste legemiddeltilberedninger inneholdende nifedipin.

Country Status (20)

Country Link
EP (1) EP0047899B2 (ja)
JP (1) JPS5914446B2 (ja)
AR (1) AR226377A1 (ja)
AT (1) ATE5761T1 (ja)
AU (1) AU558331B2 (ja)
CA (1) CA1180277A (ja)
DD (1) DD201974A5 (ja)
DE (2) DE3033919A1 (ja)
DK (1) DK154326C (ja)
FI (1) FI72648B (ja)
GR (1) GR78237B (ja)
HU (1) HU184879B (ja)
IE (1) IE51549B1 (ja)
IL (1) IL63749A (ja)
NO (1) NO157368B (ja)
NZ (1) NZ198285A (ja)
PH (1) PH24097A (ja)
PL (1) PL232951A1 (ja)
PT (1) PT73603B (ja)
ZA (1) ZA816213B (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4529733A (en) * 1983-04-06 1985-07-16 Merrell Dow Pharmaceuticals Inc. Antihypertensive 3-furoyl-1,4-dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
CH673947A5 (ja) * 1986-09-23 1990-04-30 Sandoz Ag
JPS6464659A (en) * 1987-09-03 1989-03-10 Kenbi Kogaku Kenkyusho Kk Preparation of safe and effective powder formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
JPH0298550U (ja) * 1989-01-25 1990-08-06
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
WO1996020707A1 (de) * 1994-12-29 1996-07-11 Dr. Rentschler Arzneimittel Gmbh & Co. Pharmazeutische zubereitungen, enthaltend nifedipin und verfahren zu ihrer herstellung
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
IL123505A (en) * 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
MXPA01005370A (es) 1999-09-30 2004-05-14 Penwest Pharmaceuticals Co Sistema de matriz de liberacion sostenida para farmacos altamente solubles.
EP1741712B1 (en) 2004-07-30 2011-06-15 Torrent Pharmaceuticals Ltd amorphous form of nebivolol hydrochloride and its preparation
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330727A (en) * 1960-04-19 1967-07-11 Glaxo Lab Ltd Griseofulvin with high specific surface area
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
DE2348334C2 (de) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material

Also Published As

Publication number Publication date
HU184879B (en) 1984-10-29
PL232951A1 (ja) 1982-10-11
ZA816213B (en) 1982-09-29
EP0047899B1 (de) 1984-01-04
JPS5914446B2 (ja) 1984-04-04
NZ198285A (en) 1984-04-27
EP0047899B2 (de) 1996-02-28
PT73603A (en) 1981-09-01
DK396381A (da) 1982-03-10
NO812879L (no) 1982-03-10
GR78237B (ja) 1984-09-26
DK154326B (da) 1988-11-07
FI72648B (fi) 1987-03-31
ATE5761T1 (de) 1984-01-15
IL63749A0 (en) 1981-12-31
AU558331B2 (en) 1987-01-29
DE3161838D1 (en) 1984-02-09
PH24097A (en) 1990-03-05
IL63749A (en) 1984-06-29
AR226377A1 (es) 1982-06-30
CA1180277A (en) 1985-01-02
PT73603B (en) 1982-11-10
EP0047899A1 (de) 1982-03-24
AU7506381A (en) 1982-03-18
DK154326C (da) 1995-03-13
FI812758L (fi) 1982-03-10
DD201974A5 (de) 1983-08-24
DE3033919A1 (de) 1982-04-22
IE812075L (en) 1982-03-09
JPS5750913A (en) 1982-03-25
IE51549B1 (en) 1987-01-07

Similar Documents

Publication Publication Date Title
NO157368B (no) Fremgangsmaate til fremstilling av faste legemiddeltilberedninger inneholdende nifedipin.
US5264446A (en) Solid medicament formulations containing nifedipine, and processes for their preparation
NO164817B (no) Fremgangsmaate til fremstilling av tofasede, nifedipinholdige, legemiddeltilberedninger.
US5980942A (en) Zero-order sustained release matrix tablet formulations of carbamazepine
AU2002222567B2 (en) Composition improved in solubility or oral absorbability
KR101512404B1 (ko) 디하이드로피리딘 칼슘 채널 길항제를 포함하는 향상된 의약 조성물 및 이의 준비 방법
US20070196472A1 (en) Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
NO840770L (no) Vaesketilbredninger av dihydropyridiner, en fremgangsmaate til deres fremstilling, samt deres anvendelse til bekjempelse av sykdommer
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
HU192407B (en) Process for producing antidiabetic pharmaceutical compositions for oral application
MXPA03005883A (es) Composiciones farmaceuticas que comprenden maleato de amlodipina.
GB2196852A (en) Sustained release composition
US20080274196A1 (en) Oral Pharmaceutical Suspension Compositions Of Fexofenadine
US6020384A (en) Process for the manufacture of flavanolignan preparation with improved release and absorbability, compositions obtainable thereby and their use for the preparation of pharmaceuticals
KR100846945B1 (ko) 파라세타몰을 포함하는 연하 정제
KR100281521B1 (ko) 프라바스타틴나트륨이 함유된 약제 조성물
Jachowicz Dissolution rates of partially water-soluble drugs from solid dispersion systems. II. Phenytoin
CN115518066A (zh) 一种用于治疗抗凝血的药物组合物及应用
EP0310999B1 (en) Pharmaceutical composition for piperidinoalkanol derivatives
CA2728997C (en) Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and .beta. receptor blocking agent, and use thereof
RU2141821C1 (ru) Водная суспензия сабелюзола для орального применения и способ ее изготовления
JPS5925765B2 (ja) 消化性潰瘍治療剤
NO742027L (ja)
JP3061445B2 (ja) 血管拡張剤
JPS6293230A (ja) 組合せ製剤